B cells amplify IFN-γ production by T cells via a TNF-α-mediated mechanism

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4857-4866

  Menard, Laurence C ^a   Minns, Laurie A ^a   Darche, Sylvie ^b   Mielcarz, Daniel W ^a   Foureau, David M ^a   Roos, David ^c   Dzierszinski, Florence ^d   Kasper, Lloyd H ^a   Buzoni Gatel, Dominique ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TOXOPLASMOSIS;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CHEMOKINE CCL3; CHEMOKINE CCL4; CHEMOKINES, CC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEINS; MICE; MICE, KNOCKOUT; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45449113618     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4857     Document Type: Article

References (45)

1. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
2. + T lymphocytes: molecular dynamics and immunologic consequences. Semin. Immunol. 15: 325-329.
3. Heit, A., K. M. Huster, F. Schmitz, M. Schiemann, D. H. Busch, and H. Wagner. 2004. CpG-DNA aided cross-priming by cross-presenting B cells. J. Immunol. 172: 1501-1507.
4. Hon, H., A. Oran, T. Brocker, and J. Jacob. 2005. B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J. Immunol. 174: 5233-5242.
5. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
6. Harris, D. P., S. Goodrich, A. J. Gerth, S. L. Peng, and F. E. Lund. 2005. Regulation of IFN-γ production by B effector 1 cells: essential roles for T-bet and the IFN-γ receptor. J. Immunol. 174: 6781-6790.
7. Harris, D. P., S. Goodrich, K. Mohrs, M. Mohrs, and F. E. Lund. 2005. Cutting edge: the development of IL-4-producing B cells (B effector 2 cells) is controlled by IL-4, IL-4 receptor α, and Th2 cells. J. Immunol. 175: 7103-7107.
8. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1: 475-482.
9. Martin, F., and A. C. Chan. 2004. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 20: 517-527.
10. Cross, A. H., J. L. Stark, J. Lauber, M. J. Ramsbottom, and J. A. Lyons. 2006. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 180: 63-70.
11. Edwards, J. C., and G. Cambridge. 2006. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat. Rev. Immunol. 6: 394-403.
12. Edwards, J. C., L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D. R. Close, R. M. Stevens, and T. Shaw. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350: 2572-2581.
13. Liesenfeld, O. 2002. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J. Infect. Dis. 185 (Suppl. 1): S96-S101.
14. + T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184: 597-607.
15. + T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. J. Immunol. 168: 2988-2996.
16. +-T-cell responses to transgenic ovalbumin-expressing Toxoplasma gondii during toxoplasmosis. Infect. Immun. 72: 7240-7246.
17. Burg, J. L., C. M. Grover, P. Pouletty, and J. C. Boothroyd. 1989. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 27: 1787-1792.
18. Courret, N., S. Darche, P. Sonigo, G. Milon, D. Buzoni-Gatel, and I. Tardieux. 2006. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107: 309-316.
19. Elder, P. K., C. L. French, M. Subramaniam, L. J. Schmidt, and M. J. Getz. 1988. Evidence that the functional β-actin gene is single copy in most mice and is associated with 5′ sequences capable of conferring serum- and cycloheximide-dependent regulation. Mol. Cell. Biol. 8: 480-485.
20. Crowley, M. T., C. R. Reilly, and D. Lo. 1999. Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen. J. Immunol. 163: 4894-4900.
21. Rachinel, N., D. Buzoni-Gatel, C. Dutta, F. J. Mennechet, S. Luangsay, L. A. Minns, M. E. Grigg, S. Tomavo, J. C. Boothroyd, and L. H. Kasper. 2004. The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J. Immunol. 173: 2725-2735.
22. Martin, F., and A. C. Chan. 2006. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24: 467-496.
23. Epstein, M. M., F. Di Rosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182: 915-922.
24. + T cell memory in the absence of B cells and Ig. J. Immunol. 157: 2947-2952.
25. Itano, A. A., and M. K. Jenkins. 2003. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4: 733-739.
26. Crawford, A., M. Macleod, T. Schumacher, L. Corlett, and D. Gray. 2006. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J. Immunol. 176: 3498-3506.
27. Li, W., D. Buzoni-Gatel, H. Debbabi, M. S. Hu, F. J. Mennechet, B. G. Durell, R. J. Noelle, and L. H. Kasper. 2002. CD40/CD154 ligation is required for the development of acute ileitis following oral infection with an intracellular pathogen in mice. Gastroenterology 122: 762-773.
28. Minns, L. A., L. C. Menard, D. M. Foureau, S. Darche, C. Ronet, D. W. Mielcarz, D. Buzoni-Gatel, and L. H. Kasper. 2006. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J. Immunol. 176: 7589-7597.
29. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
30. Sukumar, S., D. H. Conrad, A. K. Szakal, and J. G. Tew. 2006. Differential T cell-mediated regulation of CD23 (FcεRII) in B cells and follicular dendritic cells. J. Immunol. 176: 4811-4817.
31. Lecoanet-Henchoz, S., J. F. Gauchat, J. P. Aubry, P. Graber, P. Life, N. Paul-Eugene, B. Ferrua, A. L. Corbi, B. Dugas, C. Plater-Zyberk, et al. 1995. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity 3: 119-125.
32. Lecoanet-Henchoz, S., C. Plater-Zyberk, P. Graber, D. Gretener, J. P. Aubry, D. H. Conrad, and J. Y. Bonnefoy. 1997. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD18. Eur. J. Immunol. 27: 2290-2294.
33. Huissoon, A. P., P. Emery, P. A. Bacon, J. Gordon, and M. Salmon. 2000. Increased expression of CD23 in rheumatoid synovitis. Scand. J. Rheumatol. 29: 154-159.
34. Kleinau, S., P. Martinsson, S. Gustavsson, and B. Heyman. 1999. Importance of CD23 for collagen-induced arthritis: delayed onset and reduced severity in CD23-deficient mice. J. Immunol. 162: 4266-4270.
35. Plater-Zyberk, C., and J. Y. Bonnefoy. 1995. Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nat. Med. 1: 781-785.
36. Ribbens, C., V. Bonnet, M. J. Kaiser, B. Andre, O. Kaye, N. Franchimont, D. de Groote, Y. Beguin, and M. G. Malaise. 2000. Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clin. Exp. Immunol. 120: 194-199.
37. Holtmann, M. H., M. Schutz, P. R. Galle, and M. F. Neurath. 2002. Functional relevance of soluble TNF-α, transmembrane TNF-α and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases. Z. Gastroenterol. 40: 587-600.
38. Palladino, M. A., F. R. Bahjat, E. A. Theodorakis, and L. L. Moldawer. 2003. Anti-TNF-α therapies: the next generation. Nat. Rev. Drug Discov. 2: 736-746.
39. Plevy, S. E., C. J. Landers, J. Prehn, N. M. Carramanzana, R. L. Deem, D. Shealy, and S. R. Targan. 1997. A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 159: 6276-6282.
40. Alexopoulou, L., M. Pasparakis, and G. Kollias. 1997. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur. J. Immunol. 27: 2588-2592.
41. Menten, P., A. Wuyts, and J. Van Damme. 2002. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13: 455-481.
42. Chintalacharuvu, S. R., J. X. Wang, J. M. Giaconia, and C. Venkataraman. 2005. An essential role for CCL3 in the development of collagen antibody-induced arthritis. Immunol. Lett. 100: 202-204.
43. Banks, C., A. Bateman, R. Payne, P. Johnson, and N. Sheron. 2003. Chemokine expression in IBD: mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199: 28-35.
44. Pender, S. L., V. Chance, C. V. Whiting, M. Buckley, M. Edwards, R. Pettipher, and T. T. MacDonald. 2005. Systemic administration of the chemokine macrophage inflammatory protein 1α exacerbates inflammatory bowel disease in a mouse model. Gut 54: 1114-1120.
45. Matejuk, A., J. Dwyer, A. Ito, Z. Bruender, A. A. Vandenbark, and H. Offner. 2002. Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE. J. Neurosci. Res. 67: 680-688.